Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Neuropraxis
Gepubliceerd in: Neuropraxis 6/2016

15-11-2016 | Artikel

Neurobiologie van vitaliteit: de rol van sociaal-economische status

Auteurs: Gertjan van Dijk, Romy de Boer, Anton J. W. Scheurink, Bauke Buwalda

Gepubliceerd in: Neuropraxis | Uitgave 6/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

Mensen met een relatief lage sociaal-economische status (SES) hebben gemiddeld een slechtere gezondheid en lagere levensverwachting dan mensen met een hoge SES. Dikwijls wordt hierbij gewezen op een ongezonde levensstijl. Gewoonten zoals roken, overmatig alcoholgebruik, (te veel) ongezond eten, gecombineerd met te weinig lichaamsbeweging, zijn inderdaad aantoonbare risicofactoren voor het ontstaan van gezondheidsproblemen en deze factoren worden vaak in verband gebracht met verminderde algehele vitaliteit bij een lage SES. Bij een lage SES kan echter ook een gepercipieerde sociale ondergeschiktheid een rol spelen in de gezondheid. Daarnaast zijn keuzen met betrekking tot gezond gedrag niet altijd rationele keuzen. Psychosociale stress zou een onderliggende kernfactor kunnen zijn bij het ontstaan van sociaal-economische gezondheidsverschillen. Deze stress kan op de lange termijn gedragsmatige, metabole en fysiologische aanpassingen veroorzaken, wat uiteindelijk het risico op het ontstaan van (multi)morbiditeit en mortaliteit verhoogt. Integraal beleid is noodzakelijk om gezondheid van mensen met een lage SES te verbeteren.
vorige artikel Een matige start bij de geboorte: gevolgen op korte en langere termijn
Literatuur
1.
2.
Adler N, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff. 2002;21(2):60–76.CrossRef
3.
Michie S, Jochelson K, Markham WA, Bridle C. Low-income groups and behaviour change interventions: a review of intervention content, effectiveness and theoretical frameworks. J Epidemiol Commun Health. 2009;63:610–22.CrossRef
4.
5.
Pharos. Factsheet sociaaleconomische gezondheidsverschillen (SEGV). Utrecht: Pharos Expertisecentrum Gezondheidsverschillen; 2014.
6.
Horst A van der, Erp F van, Jong J de. Zorg blijft groeien: financiën onder druk. Trends in gezondheid en zorg. Centraal Planbureau. 2011;11.
7.
Adler NE, Rehkopf DH. U.S. disparities in health: descriptions, causes, and mechanisms. Annu Rev Public Health. 2008;29:235–52.CrossRefPubMed
8.
Lakerveld J, Verstrate L, Bot SD, Kroon A, Baan CA, Brug J, Jansen AP, Droomers M, Abma T, Stronks K, Nijpels G. Environmental interventions in low-SES neighbourhoods to promote healthy behaviour: enhancing and impeding factors. Eur J Public Health. 2014;24:390–5.CrossRefPubMed
9.
Compernolle S, Oppert JM, Mackenbach JD, Lakerveld J, Charreire H, Glonti K, Bardos H, Rutter H, Cocker K de, Cardon G, Bourdeaudhuij I de, WP3 SPOTLIGHT group. Mediating role of energy-balance related behaviors in the association of neighborhood socio-economic status and residential area density with BMI: The SPOTLIGHT study. Prev Med. 2016;86:84–91.CrossRefPubMed
10.
Broadhead WE, Kaplan BH, James SA, Wagner EH, Schoenbach VJ, Grimson R, Heyden S, Tibblin G, Gehlbach SH. The epidemiologic evidence for a relationship between social support and health. Am J Epidemiol. 1983;117(5):521–37.PubMed
11.
Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103–9.CrossRefPubMed
12.
Carroll ME, Bickel WK, Higgins ST. Nondrug incentives to treat drug abuse: laboratory and clinical developments. In: Animal research and human health: advancing human welfare through behavioral science. Washington DC: American Psychological Association; 2001. pag. 139–54.CrossRef
13.
Oyserman D, Smith GC, Elmore K. Identity-based motivation: implications for health disparities. J Soc Issues. 2014;70(2):206–25.CrossRef
14.
15.
Reno RR, Cialdini RB, Kallgren CA. The transsituational influence of social norms. J Pers Soc Psychol. 1993;64(1):104–12.CrossRef
16.
17.
Robinson E, Thomas J, Aveyard P, Higgs S. What everyone else is eating: a systematic review and meta-analysis of the effect of informational eating norms on eating behavior. J Acad Nutr Diet. 2014;114(3):414–29.CrossRefPubMed
18.
19.
Eyler AA, Brownson RC, Donatelle RJ, King AC, Brown D, Sallis JF. Physical activity social support and middle- and older-aged minority women: results from a US survey. Soc Sci Med. 1999;49(6):781–9.CrossRefPubMed
20.
Bauman AE, Reis RS, Sallis JF, Wells JC, Loos RJ, Martin BW. Lancet physical activity series working group. Correlates of physical activity: Why are some people physically active and others not? Lancet. 2012;380:21–7.CrossRef
21.
Falomir JM, Invernizzi F. The role of social influence and smoker identity in resistance to smoking cessation. Swiss J Psychol. 1999;58(2):73–84.CrossRef
22.
Phua JJ. The reference group perspective for smoking cessation. An examination of the influence of social norms and social identification with reference groups on smoking cessation self-efficacy. Psychol Addict Behav. 2013;27(1):102–12.CrossRefPubMed
23.
Hohman ZP, Crano WD, Niedbala EM. Attitude ambivalence, social norms, and behavioral intentions: developing effective antitobacco persuasive communications. Psychol Addict Behav. 2016;30(2):209–19.CrossRefPubMed
24.
Litt DM, Lewis MA. Examining a social reaction model in the prediction of adolescent alcohol use. Addict Behav. 2016;60(9):160–4.CrossRefPubMed
25.
Merrill JE, Miller MB, Balestrieri SG, Carey KB. Do my peers approve? Interest in injunctive norms feedback delivered online to college student drinkers. Addict Behav. 2016;58(7):188–93.CrossRefPubMed
26.
Cialdini R. Crafting normative messages to protect the environment. Curr Dir Psychol Sci. 2003;12(4):105–9.CrossRef
27.
Tajfel H, Turner JC. The social identity theory of intergroup behaviour. In: Psychology of intergroup relations. Chicago: Nelson-Hall; 1986. pag. 7–24.
28.
Mackenbach JP. Health inequalities: Europe in profile. Rotterdam: UK presidency of the EU; 2006.
29.
Rijkinstituut voor Volksgezondheid en Milieu (RIVM). Ziektelast in DALY’s: Wat is de bijdrage van risicofactoren? 2016. http://​www.​nationaalkompas.​nl/​gezondheid-en-ziekte/​sterfte-levensverwachtin​g-en-daly-s/​ziektelast-in-daly-s/​wat-is-de-bijdrage-van-risicofactoren/​.​ Geraadpleegd op: 8 juni 2016.
30.
Stichting Trimbos-Instituut. Ziekte en sterfte 2016. https://​www.​rokeninfo.​nl/​professionals/​gebruik-en-gevolgen/​ziekte-en-sterfte1.​ Geraadpleegd op: 14 juni 2016.
31.
Sonntag D, Schneider S, Mdege N, Ali S, Schmidt B. Beyond food promotion: a systematic review on the influence of the food industry on obesity-related dietary behaviour among children. Nutrients. 2015;7:8565–76.CrossRefPubMedPubMedCentral
32.
Drenowski A. The real contribution of added sugars and fats to obesity. Epidemiol Rev. 2007;29:160–71.CrossRef
33.
Beilby J. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/american heart association conference on scientific issues related to definition. Clin Biochem Rev. 2004;109:433–8.
34.
Dijk G van, Buwalda B. Neurobiology of the metabolic syndrome: an allostatic perspective. Eur J Pharmacol. 2008;585:137–46.CrossRefPubMed
35.
Masters RK, Reither EN, Powers DA, Yang YC, Burger AE, Link BG. The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates. Am J Public Health. 2013;103(10):1895–901.CrossRefPubMedPubMedCentral
36.
Sikorski C, Riedel C, Luppa M, Schulze B, Werner P, König HH, Riedel-Heller SG. Perception of overweight and obesity from different angles: a qualitative study. Scand J Public Health. 2012;40:271–7.CrossRefPubMed
37.
McKinnon L, Giskes K, Turrell G. The contribution of three components of nutrition knowledge to socio-economic differences in food purchasing choices. Public Health Nutr. 2014;17(8):1814–24.CrossRefPubMed
38.
Prentice AM, Rayco-Solon P, Moore SE. Insights from the developing world: thrifty genotypes and thrifty phenotypes. Proc Nutr Soc. 2005;64(2):153–61.CrossRefPubMed
39.
40.
41.
Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404(6778):661–71.PubMed
42.
Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269(5223):543–6.CrossRefPubMed
43.
Schwartz GJ, Moran TH. CCK elicits and modulates vagal afferent activity arising from gastric and duodenal sites. Ann NY Acad Sci. 1994;713:121–8.CrossRefPubMed
44.
Berthoud HR. Neural control of appetite: cross-talk between homeostatic and non-homeostatic systems. Appetite. 2004;43(3):315–7.CrossRefPubMed
45.
Berridge KC. ‘Liking’ and ‘wanting’ food rewards: brain substrates and roles in eating disorders. Phsyiol Behav. 2009;97(5):537–50.CrossRef
46.
Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Cull JG, Comings DE. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med. 1996;89(7):396–400.PubMedPubMedCentral
47.
Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, Alexoff D, Ding YS, Wong C, Ma Y, Pradhan K. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage. 2008;42(4):1537–43.CrossRefPubMedPubMedCentral
48.
Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature. 2006;443(7109):289–95.CrossRefPubMed
49.
Geronimus AT, James SA, Destin M, Graham LA, Hatzenbuehler M, Murphy M, Pearson JA, Omari A, Thompson JP. Jedi public health: Co-creating an identity-safe culture to promote health equity. SSM Popul Health. 2016;2:105–16.CrossRefPubMed
50.
Weltens N, Zhao D, Oudenhove L van. Where is the comfort in comfort foods? Mechanisms linking fat signaling, reward, and emotion. Neurogastroenterol Motil. 2014;26(3):303–15.CrossRefPubMed
51.
52.
Andrews J, Wadiwalla M, Juster RP, Lord C, Lupien SJ, Pruessner JC. Effects of manipulating the amount of social–evaluative threat on the cortisol stress response in young healthy men. Behav Neurosci. 2007;121(5):871–6.CrossRefPubMed
53.
Koolhaas JM, Bartolomucci A, Buwalda B, Boer SF de, Flügge G, Korte SM, Meerlo P, Murison R, Olivier B, Palanza P, Richter-Levin G, Sgoifo A, Steimer T, Stiedl O, Dijk G van, Wöhr M, Fuchs E. Stress revisited: a critical evaluation of the stress concept. Neurosci Biobehav Rev. 2011;35(5):1291–301.CrossRefPubMed
54.
Bose M, Oliván B, Laferrère B. Stress and obesity: the role of the hypothalamic – pituitary – adrenal axis in metabolic disease. Curr Opin Endocrinol Diabetes Obes. 2009;16:340–6.CrossRefPubMedPubMedCentral
55.
Cundiff JM, Smith TW, Baron CE, Uchino BN. Hierarchy and Health: physiological effects of interpersonal experiences associated with socioeconomic position. Health Psychol. 2016;35(4):356–65.CrossRefPubMed
56.
Buwalda B, Boer SF de, Schmidt ED, Felszeghy K, Nyakas C, Sgoifo A, Van der Vegt BJ, Tilders FJ, Bohus B, Koolhaas JM. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats. J Neuroendocrinol. 1999;11(7):513–20.CrossRefPubMed
57.
Incollingo Rodriguez AC, Epel ES, White ML, Standen EC, Seckl JR, Tomiyama AJ. Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: a systematic review. Psychoneuroendocrinology. 2015;62:301–18.CrossRefPubMed
58.
Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes. 1997;46(4):717–9.CrossRefPubMed
59.
Madiehe AM, Lin L, White C, Braymer HD, Bray GA, York DA. Constitutive activation of STAT-3 and downregulation of SOCS-3 expression induced by adrenalectomy. Am J Physiol Regul Integr Comp Physiol. 2001;281(6):R2048–R2058.PubMed
60.
Dijk G van, Vries K de, Nyakas C, Buwalda B, Adage T, Kuipers F, Kas MJ, Adan RA, Wilkinson CW, Thiele TE, Scheurink AJ. Reduced anorexigenic efficacy of leptin, but not of the melanocortin receptor agonist melanotan-II, predicts diet-induced obesity in rats. Endocrinology. 2005;146(12):5247–56.CrossRefPubMedPubMedCentral
61.
62.
Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010;35:2–16.CrossRefPubMed
63.
Logan JG, Barksdale DJ. Allostasis and allostatic load: expanding the discourse on stress and cardiovascular disease. J Clin Nurs. 2008;17(7B):201–8.CrossRefPubMed
64.
Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol Aspects Med. 2011;32:279–304.CrossRefPubMed
65.
Aschbacher K, O’Donovan A, Wolkowitz OM, Dhabhar FS, Su Y, Epel E. Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity. Psychoneuroendocrinology. 2013;38:1698–708.CrossRefPubMedPubMedCentral
66.
Ristow M, Zarse K. How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp Gerontol. 2010;45:410–8.CrossRefPubMed
67.
Hamilton KL, Miller BF. What is the evidence for stress resistence and slowed aging? Exp Gerontol. 2016;82:67–72.CrossRefPubMed
68.
Ristow M, Schmeisser S. Extending life span by increasing oxidative stress. Free Radic Biol Med. 2011;51:327–36.CrossRefPubMed
69.
Stringhini S, Polidoro S, Sacerdote C, Kelly RS, Veldhoven K van, Agnoli C, Grioni S, Tumino R, Giurdanella MC, Panico S, Mattiello A, Palli D, Masala G, Gallo V, Castagné R, Paccaud F, Campanella G, Chadeau-Hyam M, Vineis P. Life-course socioeconomic status and DNA methylation of genes regulating inflammation. Int J Epidemiol. 2015;44(4):1320–30.CrossRefPubMed
70.
Murabito JM, Yuan R, Lunetta KL. The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals. J Gerontol A Biol Sci Med Sci. 2012;67:470–9.CrossRefPubMed
71.
72.
73.
74.
Cherkas LF, Aviv A, Valdes AM, Hunkin JL, Gardner JP, Surdulescu GL, Kimura M, Spector TD. The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell. 2006;5(5):361–5.CrossRefPubMed
75.
76.
Aviv A. Telomeres and human aging: facts and fibs. Sci Aging Knowledge Environ. 2004;43:51.
77.
78.
Antunes LC, Levandovski R, Dantas G, Caumo W, Hidalgo MP. Obesity and shift work: chronobiological aspects. Nutr Res Rev. 2010;23:155–68.CrossRefPubMed
79.
Panjwani C, Caraher M. The public health responsibility deal: brokering a deal for public health, but on whose terms? Health Policy. 2014;114(2–3):163–73.CrossRefPubMed
Metagegevens
Titel
Neurobiologie van vitaliteit: de rol van sociaal-economische status
Auteurs
Gertjan van Dijk
Romy de Boer
Anton J. W. Scheurink
Bauke Buwalda
Publicatiedatum
15-11-2016
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Neuropraxis / Uitgave 6/2016
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI
https://doi.org/10.1007/s12474-016-0137-0

Andere artikelen Uitgave 6/2016

Neuropraxis 6/2016 Naar de uitgave

Artikel

Risicovol beslisgedrag bij ADHD: een metaregressieanalyse

Artikel

Een matige start bij de geboorte: gevolgen op korte en langere termijn

Report

Woorden vooraf

Artikel

Hemianopsie: gevolgen voor het dagelijks leven en de effecten van compensatietraining